New MDCG & Stakeholders Survey on MDR/IVDR Certifications and Applications Released by Notified Bodies
- Home
- regulatory updates
- New MDCG & Stakeholders Survey on MDR/IVDR Certifications and Applications Released by Notified Bodies
New MDCG & Stakeholders Survey on MDR/IVDR Certifications and Applications Released by Notified Bodies
Regulatory Affairs EU MDR EU IVDR
Monday, 27 May 2024
Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager IVD
Share
\
\
X (Twitter) 
\
\
LinkedIn 
\
\
WhatsApp 
\
\
Copy link 
\
\
Mail
On May 17th, 2024, the European Commission released the survey results of the 8th Notified Body survey on certifications and applications under the MDR and IVDR with data until February 29th, 2024.
A Notified Bodies survey on certifications and applications under MDR and IVDR.
Here are the key take home messages to share:
- The number of MDR applications per month have nearly halved in comparison to the previous survey result (from roughly 4500 applications reported for the period between June and October 2023 to roughly 2500 applications for the period between October 2023 and February 2024).
- Under MDR, in the majority of the cases (62%), it takes less than 2 months from an application lodged to a written agreement signed.
- The time to reach a new certificate under MDR is increasing, 40% of notified bodies now report a time between 13 to 18 months for QMS + Product certificates.
- For IVDR the number of applications per month is roughly 60% lower in comparison to the previous survey result (from roughly 340 applications reported for the period between June and October 2023 to roughly 140 applications for the period between October 2023 and February 2024).
- This translates in significantly less IVDR certificates being issued by the notified bodies versus the previous survey period, a drop in more than 50% (!!), from roughly 200 to roughly 100.
- The time to reach a new certificate under IVDR is increasing, 75% of notified bodies now report a time between 13 to 18 months, 17% even report timelines between 19 and 24 months.
- Only close to 800 certificates have been issued under IVDR, of which 173 Class D devices.
- Only about 1600 IVDR applications have been lodged, of which 370 Class D devices.
What does this mean for you?
Although the European Parliament recently approved another extension on the transitional provisions, don’t sit back and relax. Take into account the time you need to prepare your technical documentation in compliance with MDR/IVDR, organise your team and ensure your quality management system is also in compliance with the requirements of the regulations. Currently notified bodies still have capacity, but it is expected that by 2025 this will not be the case. The time to act is now!
Need regulatory support?
Trust our expertise to guide you through the regulatory process and achieve compliance
with ease.
Discover how we can help.
Discover more expert content
Previous
Regulatory Affairs
22 Apr 2024
New MDCG Guidance on Safety Reporting for Performance Studies of In Vitro Diagnostic Medical Devices under EU Regulation 2017/746 Released
On April 15th, 2024, the Medical Device Coordination Group (MDCG) released a new guidance document...
Regulatory Affairs
15 Mar 2024
New MDCG Guidance Released: Device-Specific Vigilance Document
The Medical Device Coordination Group (MDCG) released a Device Specific Vigilance Guidance Document...
Regulatory Affairs
6 Nov 2024
MDCG 2024-13 and MDCG 2022-5 Rev 1 released
On October 29th, 2024, the Medical Device Coordination Group (MDCG) released a new guidance (MDCG...
Regulatory Affairs
15 Mar 2024
New MDCG Guidance Released: Detailed Instructions for Clinical Investigation Plans in Medical Device Studies
New MDCG Guidance documents released: Guidance on the content of the Clinical Investigation Plan...
Regulatory Affairs
15 Nov 2024
MDCG 2023-3 Rev 1 released
On November 11th, 2024, the Medical Device Coordination Group (MDCG) released its first revision...
Regulatory Affairs
22 Apr 2024
New MDCG Guidance on Safety Reporting for Performance Studies of In Vitro Diagnostic Medical Devices under EU Regulation 2017/746 Released
On April 15th, 2024, the Medical Device Coordination Group (MDCG) released a new guidance document...
Regulatory Affairs
15 Mar 2024
New MDCG Guidance Released: Device-Specific Vigilance Document
The Medical Device Coordination Group (MDCG) released a Device Specific Vigilance Guidance Document...
Regulatory Affairs
6 Nov 2024
MDCG 2024-13 and MDCG 2022-5 Rev 1 released
On October 29th, 2024, the Medical Device Coordination Group (MDCG) released a new guidance (MDCG...
Regulatory Affairs
15 Mar 2024
New MDCG Guidance Released: Detailed Instructions for Clinical Investigation Plans in Medical Device Studies
New MDCG Guidance documents released: Guidance on the content of the Clinical Investigation Plan...
Regulatory Affairs
15 Nov 2024
MDCG 2023-3 Rev 1 released
On November 11th, 2024, the Medical Device Coordination Group (MDCG) released its first revision...
Regulatory Affairs
22 Apr 2024
New MDCG Guidance on Safety Reporting for Performance Studies of In Vitro Diagnostic Medical Devices under EU Regulation 2017/746 Released
On April 15th, 2024, the Medical Device Coordination Group (MDCG) released a new guidance document...
Regulatory Affairs
15 Mar 2024
New MDCG Guidance Released: Device-Specific Vigilance Document
The Medical Device Coordination Group (MDCG) released a Device Specific Vigilance Guidance Document...
Next
- 1
- 2
- 3
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
Twitter Widget Iframe